Abstract
Nocturia is a common symptom in the elderly and is associated with sleep fragmentation, irregular heartbeats, diabetes and stroke. It may be associated with obstructive sleep apnea-Hypopnea syndrome (OSAHS), and when present is seen more often in patients less than 50 years of age. OSAHS is often overlooked as a cause of nocturia, especially in the presence of coexisting diseases such as diabetes. OSAHS patients with frequent nocturia have higher body mass index (BMI), greater apnea-hypopnea index (AHI), and worse quality of life. Nocturia is correlated with the severity of OSAHS and the use of continuous positive airway pressure (CPAP) has shown to be beneficial. In this review, we discuss the various pathophysiologic mechanisms, clinical features and treatment options for patients with nocturia and obstructive sleep apnea-Hypopnea Syndrome.
Keywords: Aldostorone, atrial natriuretic peptide, BIPAP, CPAP, nocturia, obstructive sleep apnea-hypopnea syndrome, sympathetic surge.
Current Respiratory Medicine Reviews
Title:Nocturia in Obstructive Sleep Apnea-Hypopnea Syndrome: An Underappreciated Symptom
Volume: 9 Issue: 3
Author(s): Guy Aristide, Michael Weinstein and Girish B. Nair
Affiliation:
Keywords: Aldostorone, atrial natriuretic peptide, BIPAP, CPAP, nocturia, obstructive sleep apnea-hypopnea syndrome, sympathetic surge.
Abstract: Nocturia is a common symptom in the elderly and is associated with sleep fragmentation, irregular heartbeats, diabetes and stroke. It may be associated with obstructive sleep apnea-Hypopnea syndrome (OSAHS), and when present is seen more often in patients less than 50 years of age. OSAHS is often overlooked as a cause of nocturia, especially in the presence of coexisting diseases such as diabetes. OSAHS patients with frequent nocturia have higher body mass index (BMI), greater apnea-hypopnea index (AHI), and worse quality of life. Nocturia is correlated with the severity of OSAHS and the use of continuous positive airway pressure (CPAP) has shown to be beneficial. In this review, we discuss the various pathophysiologic mechanisms, clinical features and treatment options for patients with nocturia and obstructive sleep apnea-Hypopnea Syndrome.
Export Options
About this article
Cite this article as:
Aristide Guy, Weinstein Michael and Nair B. Girish, Nocturia in Obstructive Sleep Apnea-Hypopnea Syndrome: An Underappreciated Symptom, Current Respiratory Medicine Reviews 2013; 9 (3) . https://dx.doi.org/10.2174/1573398X113099990019
DOI https://dx.doi.org/10.2174/1573398X113099990019 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advances in Clinical Immunology, Endocrine & Metabolic Drugs: An Editorial Overview
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Histone Deacetylase Inhibitors in Cancer Treatment: A Review of the Clinical Toxicity and the Modulation of Gene Expression in Cancer Cells
Current Pharmaceutical Biotechnology An Overview of the Effect of Weight Loss on Cardiovascular Autonomic Function
Current Diabetes Reviews Recent Updates of Chemically Modified Electrodes in Pharmaceutical Analysis
Combinatorial Chemistry & High Throughput Screening New Agents to Treat Life-Threatening Fungal Infections
Current Topics in Medicinal Chemistry Is Combination Therapy of Atosiban and Nifedipine More Effective in Preterm Labor than Each Drug Alone? A Prospective Study
Current Women`s Health Reviews Antihypertensive Effect of Sesamin
Vascular Disease Prevention (Discontinued) Involvement of Hypoxia-Inducible Factors in the Dysregulation of Oxygen Homeostasis in Sepsis
Cardiovascular & Hematological Disorders-Drug Targets Snake Venom Induced Local Toxicities: Plant Secondary Metabolites as an Auxiliary Therapy
Mini-Reviews in Medicinal Chemistry Cold-induced Anaphylaxis: The Case of a 9-year-old Child and Review of the Literature
Endocrine, Metabolic & Immune Disorders - Drug Targets Fibromyalgia
Current Rheumatology Reviews New Physiological Targets Within the Kidney for Antihypertensive Therapy
Drug Design Reviews - Online (Discontinued) Treatment of Catatonia with Asenapine in a Patient with Schizotypal Personality Disorder, Psychotic Depression and Septic Shock from SARSCoV- 2 - A Case Report
CNS & Neurological Disorders - Drug Targets General or Local Anesthesia for TAVI? A Systematic Review of the Literature and Meta-Analysis
Current Pharmaceutical Design Melatonin Receptor Agonists: SAR and Applications to the Treatment of Sleep-Wake Disorders
Current Topics in Medicinal Chemistry Cardiac ATP-Sensitive Potassium Channels: A Potential Target for an Anti-Ischaemic Pharmacological Strategy
Cardiovascular & Hematological Agents in Medicinal Chemistry Spontaneous Coronary Artery Dissection: Does Being Unemployed Matter? Insights from the GSCAD Registry
Current Cardiology Reviews Treatment Possibilities for Psychosis in Parkinson's Disease with An Emphasis on the Newly Approved Drug: Pimavanserin
CNS & Neurological Disorders - Drug Targets Pharmacological Perspectives of Wasp Venom
Protein & Peptide Letters Clozapine Safety, 40 Years Later
Current Drug Safety